Similar Search Results

Quantifying gains in the war on cancer due to improved treatment and earlier detection

Seabury, Seth A.; Goldman, Dana P.; Gupta, Charu N.; … - In: Forum for health economics & policy : an evolving … 19 (2016) 1, pp. 14-139

Persistent link: https://www.econbiz.de/10011537383

A reexamination of the costs of medical R&D regulation

Philipson, Tomas J.; Sun, Eric; Goldman, Dana P.; Jena, … - In: Forum for health economics & policy : an evolving … 15 (2012) 3, pp. 132-159

Persistent link: https://www.econbiz.de/10009656216

Health and health care of Medicare beneficiaries in 2030

Gaudette, Étienne; Tysinger, Bryan; Cassil, Alwyn; … - In: Forum for health economics & policy : an evolving … 18 (2015) 2, pp. 75-96

Persistent link: https://www.econbiz.de/10011440589

Intellectual property, information technology, biomedical research, and marketing of patented products

Goldman, Dana P.; Lakdawalla, Darius - 2012

Persistent link: https://www.econbiz.de/10011498385

Chapter Thirteen. Intellectual Property, Information Technology, Biomedical Research, and Marketing of Patented Products

Goldman, Dana; Lakdawalla, Darius - In: Handbook of health economics : volume 2, (pp. 825-872). 2011

Intellectual property rights are viewed as essential to medical innovation, but very often involve social costs due to patent monopolies and other inefficiencies. We review the positive theory of innovation in health care, as it relates to the determination of innovation demand and supply. The...

Persistent link: https://www.econbiz.de/10014025575